A review of treatment options for Graves’ disease: why total thyroidectomy is a viable option in selected patients
Graves’ disease is the most common cause of hyperthyroidism. If left untreated, patients may have multiple systemic complications such as cardiac, reproductive, and skeletal disease. Thionamides, such as methimazole and propylthiouracil, and I131 iodine ablation are the most commonly prescribed trea...
Main Authors: | Vinuta Mohan, Robert Lind |
---|---|
Format: | Article |
Language: | English |
Published: |
Greater Baltimore Medical Center
2016-09-01
|
Series: | Journal of Community Hospital Internal Medicine Perspectives |
Subjects: | |
Online Access: | http://www.jchimp.net/index.php/jchimp/article/view/32369/pdf_200 |
Similar Items
-
Pre-treatment Neutropenia in Children and Adolescents with Autoimmune Hyperthyroidism
by: Melissa Kaori S. Litao, et al.
Published: (2021-09-01) -
Efficacy of methimazole before the administration of radioactive iodine in the management of Graves’ disease: a systematic review and meta-analysis
by: Ikeoluwapo Kendra Bolakale-Rufai, et al.
Published: (2023-01-01) -
Comparison of clinical efficacy of antithyroid drugs, radioactive iodine, and thyroidectomy for treatment of patients with graves' disease, toxic thyroid adenoma, and toxic multinodular goiter
by: Rashed Bawand, et al.
Published: (2022-01-01) -
Functional thyroid disorders in the pharmacy setting: How can we help our patients?
by: Pecikoza Uroš
Published: (2022-01-01) -
Efficacy and Safety of Long-Term Methimazole versus Radioactive Iodine in the Treatment of Toxic Multinodular Goiter
by: Fereidoun Azizi, et al.
Published: (2022-12-01)